Skip to main content
Springer Nature Link
Log in

Bacterial Vaginitis and Vaginosis

  • Chapter
  • First Online:
Sexually Transmitted Infections

  • 1052 Accesses

Abstract

Vaginal conditions related to microorganisms represent a diverse group of clinical conditions, and it must be understood that from a clinical standpoint that the common complaints involve prokaryotic and eukaryotic organisms as well as non-infectious causes, all of which must be included in clinician evaluations. From a scientific point of view, the topic of this chapter is highly intertwined with the indigenous microbiota of the lower female genital tract. Consequently, this chapter will not consider the fungal causes of vaginal symptoms (Candida) or protozoon (Trichomonas) organisms causing vaginitis or non-microbial conditions. Other bacterial agents including Chlamydia and Neisseria gonorrhea (usually confined to the cervix and only involving the vagina when it is in an atrophic condition) or syphilis which causes ulceration of the vaginal epithelium are handled elsewhere.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Peterson J, Garges S, Giovanni M, NIH HMP Working Group, et al. The NIH human microbiome project. Genome Res. 2009;19:2317–23. https://doi.org/10.1101/gr.096651.109.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Proctor LM. The human microbiome project in 2011 and beyond. Cell Host Microbe. 2011;10:287–91.

    Article  PubMed  CAS  Google Scholar 

  3. Kolde R, Franzosa EA, Rahnavard G, Hall AB, Vlamakis H, Stevens C, Daly MJ, Xavier RJ, Huttenhower C. Host genetic variation and its microbiome interactions within the human microbiome project. Genome Med. 2018;10:6. https://doi.org/10.1186/s13073-018-0515-8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Gonzalez A, Clemente JC, Shade A, Metcalf JL, Song S, Prithiviraj B, Palmer BE, Knight R. Our microbial selves: what ecology can teach us. EMBO Rep. 2011;12:775–84.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Oakley BB, Fiedler TL, Marrazzo JM, Fredricks DN. Appl environ diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Microbiology. 2008;74:4898–909.

    CAS  Google Scholar 

  6. Xia Q, Cheng L, Zhang H, Sun S, Liu F, Li H, Yuan J, Liu Z, Diao Y. Identification of vaginal bacteria diversity and it's association with clinically diagnosed bacterial vaginosis by denaturing gradient gel electrophoresis and correspondence analysis. Infect Genet Evol. 2016;44:479–86.

    Article  PubMed  CAS  Google Scholar 

  7. Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR, Forney LJ. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology. 2004;150(Pt 8):2565–73.

    Article  PubMed  CAS  Google Scholar 

  8. van de Wijgert J, Borgdorf H, Verhelst R, Crucitti T, Francis S, Verstraelin H, Jasper V. The vaginal microbiota: what have we learned after a decade of molecular characterization? Public Libr Sci. 2014;9(8):e105998. https://doi.org/10.1371/journal.pone.0105998.

    Article  CAS  Google Scholar 

  9. Robinson CJ, Bohannan BJ, Young VB. From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev. 2010;74:453–76.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Zhou X, Brotman RM, Gajer P, Abdo Z, Schüette U, Ma S, Ravel J, Forney LJ. Recent advances in understanding the microbiology of the female reproductive tract and the causes of premature birth. Infect Dis Obstet Gynecol. 2010;2010:737425.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Vaneechoutte M. Lactobacillus iners, the unusual suspect. Res Microbiol. 2017;168(9-10):826–36.

    Article  PubMed  Google Scholar 

  12. Saulnier DM, Santos F, Roos S, Mistretta TA, Spinler JK, Molenaar D, Teusink B, Versalovic J. Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS One. 2011;6(4):e18783.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Freitas AC, Hill JE. Quantification, isolation and characterization of Bifidobacterium from the microbiomes of reproductive aged women. Anaerobe. 2017;47:145–56.

    Article  PubMed  Google Scholar 

  14. Dubos R, Schaedle RW. The digestive tract as an ecosystem. Am J Med Sci. 1964;248:267–72.

    Article  PubMed  CAS  Google Scholar 

  15. Spear GT, French AL, Gilbert D, Zariffard MR, Mirmonsef P, Sullivan TH, Spear WW, Landay A, Micci S, Lee BH, Hamaker BR. Human α-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus. J Infect Dis. 2014;10:1019–28.

    Article  CAS  Google Scholar 

  16. Nunn KL, Forney LJ. Unraveling the dynamics of the human vaginal microbiome. Yale J Biol Med. 2016;89:331–7.

    PubMed  PubMed Central  Google Scholar 

  17. Mirmonsef P, Hotton AL, Gilbert D, Burgad D, Landay A, Weber KM, Cohen M, Ravel J, Spear GT. Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH. PLoS One. 2014;9(7):e102467.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Mitchell CM, Srinivasan S, Zhan X, Wu MC, Reed SD, Guthrie KA, LaCroix AZ, Fiedler T, Munch M, Liu C, Hoffman NG, Blair IA, Newton K, Freeman EW, Joffe H, Cohen L, Fredricks DN. Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis. Menopause. 2017;24(10):1160–6.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Lewis RM, Weinstein L. The production of vaginal acidity by estrin, its importance in the treatment of gonorrheal vaginitis. Surg Gynecol Obstet. 1936;63:640–3.

    Google Scholar 

  20. Weinstein L, Howard JH. The effect of estrogenic hormone on the H-ion concentration and the bactericidal content of the human vagina, with special reference to the Döderlein bacillus. Am J Obstet Gynecol. 1939;37:698–703.

    Article  Google Scholar 

  21. Weinstein L, Wawro NW, Worthington RV, Allen E. The influence of estrogenic hormone on the H-ion concentration and bacterial flora of the vagina of the immature monkey. Yale J Biol Med. 1938;11:141–8.

    PubMed  PubMed Central  CAS  Google Scholar 

  22. Weinstein L, Howard JH. The incidence of the Döderlein vaginal bacillus during the post-climacterium. Yale J Biol Med. 1937;10(2):185–90.

    PubMed  PubMed Central  CAS  Google Scholar 

  23. Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun. 1999;67(10):5170–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Boskey ER, Cone RA, Whaley KJ, Moench TR. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod. 2001;16(9):1809–13.

    Article  PubMed  CAS  Google Scholar 

  25. O’Hanlon DE, Moench TR, Cone RA. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One. 2013;8(11):e80074.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Rashad AL, Toffler WL, Wolf N, Thornburg K, Kirk EP, Ellis G, Whitehead WE. Vaginal PO2 in healthy women and in women infected with Trichomonas vaginalis: potential implications for metronidazole therapy. Am J Obstet Gynecol. 1992;166(2):620–4.

    Article  PubMed  CAS  Google Scholar 

  27. Ng KYB, Mingels R, Morgan H, Macklon N, Cheong Y. In vivo oxygen, temperature and pH dynamics in the female reproductive tract and their importance in human conception: a systematic review. Hum Reprod Update. 2018;24(1):15–34.

    Article  PubMed  Google Scholar 

  28. Strus M, Brzychczy-Włoch M, Gosiewski T, Kochan P, Heczko PB. The in vitro effect of hydrogen peroxide on vaginal microbial communities. FEMS Immunol Med Microbiol. 2006;48(1):56–63.

    Article  PubMed  CAS  Google Scholar 

  29. Tachedjian G, O’Hanlon RJ. The implausible “in vivo” role of hydrogen peroxide as an antimicrobial factor produced by vaginal microbiota. Microbiome. 2018;6:29.

    Article  PubMed  PubMed Central  Google Scholar 

  30. V Sgibnev A, A Kremleva E. Vaginal protection by H2O2-producing Lactobacilli. Jundishapur J Microbiol. 2015;8(10):e22913.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Shaw JL, Smith CR, Diamandis EP. Proteomic analysis of human cervico-vaginal fluid. J Proteome Res. 2007;6(7):2859–65.

    Article  PubMed  CAS  Google Scholar 

  32. Birse KM, Burgener A, Westmacott GR, McCorrister S, Novak RM, Ball TB. Unbiased proteomics analysis demonstrates significant variability in mucosal immune factor expression depending on the site and method of collection. PLoS One. 2013;8(11):e79505.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Kalyoussef S, Nieves E, Dinerman E, Carpenter C, Shankar V, Oh J, Burd B, Angeletti RH, Buckheit KW, Fredricks DN, Madan RP, Keller MJ, Herold BC. Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretions. PLoS One. 2012;7(11):e49506.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Borgdorff H, Gautam R, Armstrong SD, Xia D, Ndayisaba GF, van Teijlingen NH, Geijtenbeek TB, Wastling JM, van de Wijgert JH. Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier. Mucosal Immunol. 2016;9:621–33.

    Article  PubMed  CAS  Google Scholar 

  35. Radtke AL, Quayle AJ, Herbst-Kralovetz MM. Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model. Biol Reprod. 2012;87:132.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Murphy K, Richardson BA, Dezzutti CS, Marrazzo J, Hillier SL, Hendrix CW, Herold BC. Levels of genital tract defensins and cytokines differ between HIV-uninfected US and African women. Am J Reprod Immunol. 2015;74:313–22.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Lepargneur JP, Abbal M. Innate and adaptative immunity of the female genital tract. J Gynecol Obstet Biol Reprod. 2012;41:612–22.

    Article  Google Scholar 

  38. Cummins JE, Christensen L, Lennox JL, Bush TJ, Wu Z, Malamud D, Evans-Strickfaden T, Siddig A, Caliendo AM, Hart CE, Dezzutti CS. Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load. AIDS Res Hum Retrovir. 2006;22:788–95.

    Article  PubMed  CAS  Google Scholar 

  39. Frew L, Makieva S, McKinlay AT, McHugh BJ, Doust A, Norman JE, Davidson DJ, Stock SJ. Human cathelicidin production by the cervix. PLoS One. 2014;9(8):e103434.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Kim TK, Thomas SM, Ho M, Sharma S, Reich CI, Frank JA, Yeater KM, Biggs DR, Nakamura N, Stumpf R, Leigh SR, Tapping RI, Blanke SR, Slauch JM, Gaskins HR, Weisbaum JS, Olsen GJ, Hoyer LL, Wilson BA. Heterogeneity of vaginal microbial communities within individuals. J Clin Microbiol. 2009;47(4):1181–9. https://doi.org/10.1128/JCM.00854-08.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Larsen B, Galask RP. Vaginal microflora: practical and theoretical relevance. Obstet Gynecol. 1980;100s:55.

    Google Scholar 

  42. Larsen B, Markovetz AJ, Galask RP. Quantitative alterations in the genital microflora of female rats in relation to the estrous cycle. J Infect Dis. 1976;134:486–9.

    Article  PubMed  CAS  Google Scholar 

  43. Larsen B, Markovetz AJ, Galask RP. The bacterial flora of the female rat genital tract. Proc Soc Exp Biol Med. 1976;151:571–4.

    Article  PubMed  CAS  Google Scholar 

  44. Brooks JP, Buck GA, Chen G, Diao L, Edwards DJ, Fettweis JM, Huzurbazar S, Rakitin A, Satten GA, Smirnova E, Waks Z, Wright ML, Yanover C, Zhou YH. Changes in vaginal community state types reflect major shifts in the microbiome. Microb Ecol Health Dis. 2017;28(1):1303265.

    PubMed  PubMed Central  Google Scholar 

  45. DiGiulio DB, Callahan BJ, McMurdie PJ, Costello EK, Lyell DJ, Robaczewska A, Sun CL, Goltsman DS, Wong RJ, Shaw G, Stevenson DK, Holmes SP, Relman DA. Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci U S A. 2015;112(35):11060–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  46. Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines, recommendation report 2015. MMWR Morb Mortal Wkly Rep. 2015;64:1–135.

    Google Scholar 

  47. Jespers V, van de Wijgert J, Cools P, Verhelst R, Verstraelen H, Delany-Moretlwe S, Mwaura M, Ndayisaba GF, Mandaliya K, Menten J, Hardy L, Crucitti T, Vaginal Biomarkers Study Group. The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women. BMC Infect Dis. 2015;15:115.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol. 1955;69(5):962–76.

    Article  PubMed  CAS  Google Scholar 

  49. Chen XS. Challenges in responses to syphilis epidemic. Lancet Infect Dis. 2017;17:793–4.

    Article  PubMed  Google Scholar 

  50. Myrhaug HT, Brurberg KG, Kirkehei I, Reinar LM, editors. Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2010 May. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 11-2010. NIPH Systematic Reviews: Executive Summaries. Treatment of Pregnant Women with Asymptomatic Bacterial Vaginosis with Clindamycin.

    Google Scholar 

  51. Lokken EM, Balkus JE, Kiarie J, Hughes JP, Jaoko W, Totten PA, McClelland RS, Manhart LE. Association of recent bacterial vaginosis with acquisition of Mycoplasma genitalium. Am J Epidemiol. 2017;186:194–201.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Wilson JD, Lee RA, Balen AH, Rutherford AJ. Bacterial vaginal flora in relation to changing oestrogen levels. Int J STD AIDS. 2007;18:308–11.

    Article  PubMed  CAS  Google Scholar 

  53. Nelson TM, Borgogna JC, Michalek RD, Roberts DW, Rath JM, Glover ED, Ravel J, Shardell MD, Yeoman CJ, Brotman RM. Cigarette smoking is associated with an altered vaginal tract metabolomic profile. Sci Rep. 2018;8:852.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  54. Wessels JM, Lajoie J, Vitali D, Omollo K, Kimani J, Oyugi J, Cheruiyot J, Kimani M, Mungai JN, Akolo M, Stearns JC, Surette MG, Fowke KR, Kaushic C. Association of high-risk sexual behavior with diversity of the vaginal microbiota and abundance of Lactobacillus. PLoS One. 2017;12(11):e0187612.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Dahn A, Saunders S, Hammond JA, Carter D, Kirjavainen P, Anukam K, Reid G. Effect of bacterial vaginosis, Lactobacillus and Premarin estrogen replacement therapy on vaginal gene expression changes. Microbes Infect. 2008;10:620–7.

    Article  PubMed  CAS  Google Scholar 

  56. Sha BE, Chen HY, Wang QJ, Zariffard MR, Cohen MH, Spear GT. Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol. 2005;43:4607–12.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Kharsany AB, Hoosen AA, Van den Ende J. Antimicrobial susceptibilities of Gardnerella vaginalis. Antimicrob Agents Chemother. 1993;37:2733–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  58. Woodman Z. Can one size fit all? Approach to bacterial vaginosis in sub-Saharan Africa. Ann Clin Microbiol Antimicrob. 2016;11:15–6.

    Google Scholar 

  59. Mastromarino P, Vitali B, Mosca L. Bacterial vaginosis: a review on clinical trials with probiotics. New Microbiol. 2013;36:229–38.

    PubMed  Google Scholar 

  60. Reichman O, Akins R, Sobel JD. Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis. Sex Transm Dis. 2009;36(11):732–4.

    Article  PubMed  CAS  Google Scholar 

  61. McClelland RS, Richardson BA, Hassan WM, Chohan V, Lavreys L, Mandaliya K, Kiarie J, Jaoko W, Ndinya-Achola JO, Baeten JM, Kurth AE, Holmes KK. Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis. 2008;197(10):1361–8.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Thinkhamrop J, Hofmeyr GJ, Adetoro O, Lumbiganon P, Ota E. Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity. Cochrane Database Syst Rev. 2015;1:CD002250. https://doi.org/10.1002/14651858.CD002250.pub2.

    Article  PubMed  Google Scholar 

  63. Donders GGG, Bellen G, Grinceviciene S, Ruban K, Vieira-Baptista P. Aerobic vaginitis: no longer a stranger. Res Microbiol. 2017;168(9-10):845–58.

    Article  PubMed  Google Scholar 

  64. Marconi C, Donders GGG, Bellen G, Brown DR, Prada CMGL, Silva MG. Sialidase activity in aerobic vaginitis is equal to levels during bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol. 2013;167:205–9.

    Article  PubMed  CAS  Google Scholar 

  65. Donders GGG, Vereecken A, Bosmans E, Spitz B. Vaginal cytokines in normal pregnancy. Am J Obstet Gynecol. 2003;189:1433–8.

    Article  PubMed  CAS  Google Scholar 

  66. Cauci S, Hitti J, Noonan C, Agnew K, Quadifoglio F, Hillier SL. Vaginal hydrolytic enzymes, immunoglobulin A against Gardnerella vaginalis toxin and risk of early preterm birth among women in preterm labor with bacterial vaginosis or intermediate flora. Am J Obstet Gynecol. 2002;187:877–81.

    Article  PubMed  Google Scholar 

  67. Mardh PA, Novikova N, Niklasson O, Bekassy Z, Scude L. Leukocytes esterase activity in vaginal fluid of pregnant and non-pregnant women with vaginitis/vaginosis and controls. Infect Dis Obstet Gynecol. 2003;11:19–26.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  68. Santiago GL, Deschagt P, ElAila N, Kiama TN, Vestraelen H, Jefferson KK. Gardnerella vaginalis comprises three distinct genotypes of which only two produce sialidase. Am J Obstet Gynecol. 2011;204(450):e1–7.

    Google Scholar 

  69. Briselden A, Stevens C, Hillier SL. Sialidases (neuraminidases) in bacterial vaginosis-associated microflora. J Clin Microbiol. 1992;30:663–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  70. Reichman O, Sobel J. Desquamative inflammatory vaginitis. Best Pract Res Clin Obstet Gynaecol. 2014;28:1042–50.

    Article  PubMed  Google Scholar 

  71. Liang Q, Li N, Song S, Zhang A, Li N, Duan Y. High dose nifuratel for simple and mixed aerobic vaginitis, a prospective single center open label cohort study. J Obstet Gynaecol Res. 2016;42:1354–60.

    Article  PubMed  CAS  Google Scholar 

  72. Petersen E, Weissenbacher E, Hengst P, Spitzbart H, Wolfgang W, Wolff F. Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. Artzneimittelforschung. 2011;52:706–15.

    Article  Google Scholar 

  73. Donders GG, Gonzaga A, Marconi C, Donders F, Michaels T, Eggermont N. Increased pH in Ugandan women: what does it indicate? Eur J Clin Microbiol Infect Dis. 2016;35:1297–303.

    Article  PubMed  CAS  Google Scholar 

  74. Smieja M. Current indications for the use of clindamycin: a critical review. Can J Infect Dis. 1998;9:22–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  75. Sobel JD. Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy. Am J Obstet Gynecol. 1994;171:1215–20.

    Article  PubMed  CAS  Google Scholar 

  76. Aroutecheva A, Simones JA, Schott S, Faro S. The inhibitory effect of clindamycin on Lactobacillus in vitro. Infect Dis Obstet Gynecol. 2001;9:239–44.

    Article  Google Scholar 

  77. Tempera G, Bonfiglio G, Cammarata E, Corsello S, Cianci A. Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study. Int J Antimicrob Agents. 2004;24:85–8.

    Article  PubMed  CAS  Google Scholar 

  78. Wang C, Han C, Geng N, Fan A, Wang Y, Yue Y. Efficacy of oral moxifloxacin for aerobic vaginitis. Eur J Clin Microbiol Infect Dis. 2016;35:95–101.

    Article  PubMed  CAS  Google Scholar 

  79. Mohammadzedah F, Dolatian M, Majd HA. Diagnostic value of Amsel’s criteria for diagnosis of bacterial vaginosis. Global Health Sci. 2015;7:8–14.

    Google Scholar 

  80. Money D. The laboratory diagnosis of bacterial vaginosis. Can J Infect Dis Microbiol. 2005;16:77–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Sciences, University of Trieste, Trieste, Italy

    Francesco De Seta

  2. Institute for Maternal and Child Health-IRCCS “Burlo Garofolo”, Trieste, Italy

    Francesco De Seta

  3. SSD of Advanced Microbiology Diagnosis and Translational Research, Institute for Maternal and Child Health, Trieste, Italy

    Manola Comar

  4. University of Florence, Florence, Italy

    Secondo Guaschino

  5. Division of Biomedical Sciences, Marian University College of Osteopathic Medicine, Indianapolis, IN, USA

    Bryan Larsen

Authors
  1. Francesco De Seta
    View author publications

    Search author on:PubMed Google Scholar

  2. Manola Comar
    View author publications

    Search author on:PubMed Google Scholar

  3. Secondo Guaschino
    View author publications

    Search author on:PubMed Google Scholar

  4. Bryan Larsen
    View author publications

    Search author on:PubMed Google Scholar

Editor information

Editors and Affiliations

  1. STI/HIV Unit, San Gallicano Dermatological Institute, IRCCS, Rome, Italy

    Antonio Cristaudo

  2. STI/HIV Unit, San Gallicano Dermatological Institute, IRCCS, Rome, Italy

    Massimo Giuliani

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

De Seta, F., Comar, M., Guaschino, S., Larsen, B. (2020). Bacterial Vaginitis and Vaginosis. In: Cristaudo, A., Giuliani, M. (eds) Sexually Transmitted Infections . Springer, Cham. https://doi.org/10.1007/978-3-030-02200-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-02200-6_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-02199-3

  • Online ISBN: 978-3-030-02200-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics